Asian Spectator

Times Advertising

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

  • Written by PR Newswire Asia - Asian Spectator
  • PYC has developed a new drug candidate for the >5 million people worldwide[1] with Polycystic Kidney Disease (PKD)
  • This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2]
  • PKD is a life-changing disease affecting 1 in every 1,000 people[3]
  • Half of the patient...

More Articles ...

  1. Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Magazine

Algorithms don’t care: how AI worsens the double burden for Indonesia’s female gig workers

Artificial intelligence is often celebrated as the future of work. It is efficient, innovative and neutral. Yet, for many women in Indonesia’s gig economy, AI feels like a source of mounting pre...

Tes jenis kelamin atlet untuk melarang trasgender justru berisiko menggagalkan perempuan interseks ikut olimpiade

Tes jenis kelamin di olahraga elite memiliki sejarah panjang yang tidak konsisten.anton5146/iStock via Getty Images PlusPada 26 Maret 2026, Komite Olimpiade Internasional (IOC) mengumumkan kebijakan b...

Loker di Indonesia: Perusahaan khawatir Gen Z lembek, tapi enggan rekrut senior yang tahan banting

● Kondisi ketenagakerjaan nasional berada dalam tahap yang memprihatinkan sejak lama.● Para pemberi kerja enggan merekrut Gen Z, tapi juga emoh merekrut pekerja dari generasi senior.●...